These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24625581)

  • 1. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.
    Chi PD; Liu W; Chen H; Zhang JP; Lin Y; Zheng X; Liu W; Dai S
    PLoS One; 2014; 9(3):e91080. PubMed ID: 24625581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib.
    Tang M; Song C; Zhang Y; Xu X; Wang C; Zhang Z; Chen T
    Lipids Health Dis; 2021 Nov; 20(1):165. PubMed ID: 34801029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of a reduction in the level of high-density lipoprotein-cholesterol in patients with non-small-cell lung cancer undergoing radical resection and adjuvant chemotherapy: a retrospective observational study.
    Luo F; Zeng KM; Cao JX; Zhou T; Lin SX; Ma WJ; Yang YP; Zhang ZH; Lu FT; Huang Y; Zhao HY; Zhang L
    Lipids Health Dis; 2021 Sep; 20(1):109. PubMed ID: 34544437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio Can Predict Prognosis in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study.
    Li J; Ma C; Yuan X; Wang X; Li N; Yu R; Liao H
    Curr Oncol; 2022 Aug; 29(9):6125-6136. PubMed ID: 36135050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prognostic value of detection of serum C-reactive protein in the patients with stage I lung cancer].
    Xu Y; Li Z; Shen-Tu Y
    Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):400-3. PubMed ID: 21569644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].
    Shen L; Li ZM; Lu S
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High BMI and low HDL-C predict the chemotherapy-related hepatic dysfunction in Chinese advanced NSCLC patients.
    Lv Y; Ding XS; Li Y; An X; Miao LY
    Cancer Biomark; 2016; 16(1):89-97. PubMed ID: 26835709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.
    Li X; Tang H; Wang J; Xie X; Liu P; Kong Y; Ye F; Shuang Z; Xie Z; Xie X
    Breast; 2017 Apr; 32():1-6. PubMed ID: 27939967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG; Chen HL; Lu HY
    BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of preoperative serum triglycerides and high-density lipoproteins cholesterol in patients with non-small cell lung cancer: a retrospective study.
    Ma C; Wang X; Guo J; Liu P
    Lipids Health Dis; 2021 Oct; 20(1):69. PubMed ID: 34598703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
    Kanoh Y; Abe T; Masuda N; Akahoshi T
    Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased pretreatment serum cholesterol level is related with poor prognosis in resectable non-small cell lung cancer.
    Li JR; Zhang Y; Zheng JL
    Int J Clin Exp Pathol; 2015; 8(9):11877-83. PubMed ID: 26617943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers.
    Akamine T; Takada K; Toyokawa G; Kinoshita F; Matsubara T; Kozuma Y; Haratake N; Takamori S; Hirai F; Tagawa T; Okamoto T; Yoneshima Y; Okamoto I; Shimokawa M; Oda Y; Nakanishi Y; Maehara Y
    Surg Oncol; 2018 Mar; 27(1):88-94. PubMed ID: 29549910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
    Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
    Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum C-reactive protein level in non-small cell lung cancer.
    Hara M; Matsuzaki Y; Shimuzu T; Tomita M; Ayabe T; Enomoto Y; Onitsuka T
    Anticancer Res; 2007; 27(4C):3001-4. PubMed ID: 17695486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.
    Que Y; Jiang F; Liu L; Li Y; Chen Y; Qiu H; Zhou Z; Zhang X
    Medicine (Baltimore); 2015 May; 94(18):e844. PubMed ID: 25950696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
    Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
    Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.